Favorite

More to Drug Story 

Dale Brumfield's Back Page piece on Avastin (“Obama's Drug War,” Jan. 19) shows a strong political bias; after doing some research you will see a different perspective. Business Week's article on the subject stated: “Avastin was approved for breast cancer in February 2008 based on preliminary evidence suggesting it slowed disease progression. Two follow-up trials showed Avastin didn't prolong survival in women with breast cancer or improve symptoms, and the drug had a smaller effect on tumor growth than the Food and Drug Administration had expected. The agency decided the benefits didn't outweigh potential risks of serious bleeding, heart attacks and kidney damage.” I believe the FDA is supposed to determine the safety of food and drugs, so it appears it is just doing its job.
Kathy Kurtz
Henrico
Favorite

Comments

Subscribe to this thread:

Add a comment

Connect with Style Weekly

Newsletter Sign-Up

The Flash
The Bite
The Scoop

Copyright © 2018 Style Weekly
Richmond's alternative for news, arts, culture and opinion
All rights reserved
Powered by Foundation